Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Major

Showing results (191-200 of 217) with videos related to

Pageof 22
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2018
Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosisBrienne A McKenzie, Manmeet K Mamik, Leina B Saito, et al.
Journal of Neurovirology|June 29, 2000
Mechanisms of leukocyte trafficking into the CNSD T Wu, S E Woodman, J M Weiss, et al.
Journal of Neurology|October 14, 2016
The emergence of neuroepidemiology, neurovirology and neuroimmunology: the legacies of John F. Kurtzke and Richard 'Dick' T. JohnsonEric J Kildebeck, Ram Narayan, Avindra Nath, et al.
International Journal of Cancer|October 23, 2004
Investigation of human brain tumors for the presence of polyomavirus genome sequences by two independent laboratoriesDana E M Rollison, Utaiwan Utaipat, Caroline Ryschkewitsch, et al.
The New England Journal of Medicine|February 4, 1988
Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathyS A Houff, E O Major, D A Katz, et al.
Journal of Medical Virology|August 26, 2003
HIV-2 derived lentiviral vectors: gene transfer in Parkinson's and Fabry disease models in vitroJenice D'Costa, Judith Harvey-White, Pankaj Qasba, et al.
Neurology|November 15, 2011
Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MSJ Kuhle, R Gosert, R Bühler, et al.
JAMA Neurology|March 26, 2014
JC virus in CD34+ and CD19+ cells in patients with multiple sclerosis treated with natalizumabElliot M Frohman, Maria Chiara Monaco, Gina Remington, et al.
Glia|September 4, 2020
Intranasal anti-caspase-1 therapy preserves myelin and glucose metabolism in a model of progressive multiple sclerosisLeina B Saito, Jason P Fernandes, Mackenzie J Smith, et al.
Journal of Neurovirology|October 27, 2015
2nd International Conference on Progressive Multifocal Leukoencephalopathy (PML) 2015: JCV virology, progressive multifocal leukoencephalopathy pathogenesis, diagnosis and risk stratification, and new approaches to prevention and treatmentAndriani C Patera, Scott L Butler, Paola Cinque, et al.
Pageof 22

Showing results (191-200 of 217) with videos related to

Sort By:
Pageof 22
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2018
Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosisBrienne A McKenzie, Manmeet K Mamik, Leina B Saito, et al.
Journal of Neurovirology|June 29, 2000
Mechanisms of leukocyte trafficking into the CNSD T Wu, S E Woodman, J M Weiss, et al.
Journal of Neurology|October 14, 2016
The emergence of neuroepidemiology, neurovirology and neuroimmunology: the legacies of John F. Kurtzke and Richard 'Dick' T. JohnsonEric J Kildebeck, Ram Narayan, Avindra Nath, et al.
International Journal of Cancer|October 23, 2004
Investigation of human brain tumors for the presence of polyomavirus genome sequences by two independent laboratoriesDana E M Rollison, Utaiwan Utaipat, Caroline Ryschkewitsch, et al.
The New England Journal of Medicine|February 4, 1988
Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathyS A Houff, E O Major, D A Katz, et al.
Journal of Medical Virology|August 26, 2003
HIV-2 derived lentiviral vectors: gene transfer in Parkinson's and Fabry disease models in vitroJenice D'Costa, Judith Harvey-White, Pankaj Qasba, et al.
Neurology|November 15, 2011
Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MSJ Kuhle, R Gosert, R Bühler, et al.
JAMA Neurology|March 26, 2014
JC virus in CD34+ and CD19+ cells in patients with multiple sclerosis treated with natalizumabElliot M Frohman, Maria Chiara Monaco, Gina Remington, et al.
Glia|September 4, 2020
Intranasal anti-caspase-1 therapy preserves myelin and glucose metabolism in a model of progressive multiple sclerosisLeina B Saito, Jason P Fernandes, Mackenzie J Smith, et al.
Journal of Neurovirology|October 27, 2015
2nd International Conference on Progressive Multifocal Leukoencephalopathy (PML) 2015: JCV virology, progressive multifocal leukoencephalopathy pathogenesis, diagnosis and risk stratification, and new approaches to prevention and treatmentAndriani C Patera, Scott L Butler, Paola Cinque, et al.
Pageof 22